AllSight
Companies · CTMX · Pharmaceutical Preparations

CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics, Inc. (CTMX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Aug 6, 2026
Revenue missed sharply, while pipeline progress and cash runway held steady
Related companies in Pharmaceutical Preparations
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact